Atherosclerosis
Volume 148, Issue 1 , Pages 125-129, January 2000

Genetic polymorphism of heparan sulfate proteoglycan (Perlecan, HSPG2), lipid profiles and coronary artery disease in the Australian population

Cardiovascular Genetics Laboratory, Ground Floor, South Wing, Edmund Blacket Building, Prince of Wales Hospital, Randwick, Sydney, NSW 2031, Australia

Received 21 January 1999; received in revised form 5 April 1999; accepted 2 June 1999. published online 16 August 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0021-9150(99)00213-0

Atherosclerosis
Volume 148, Issue 1 , Pages 125-129, January 2000

Article Tools

* Image Usage & Resolution